myositis patient
Recently Published Documents


TOTAL DOCUMENTS

7
(FIVE YEARS 0)

H-INDEX

3
(FIVE YEARS 0)

2020 ◽  
Vol 72 (11) ◽  
pp. 1636-1644
Author(s):  
Christine G. Parks ◽  
Jesse Wilkerson ◽  
Kathryn M. Rose ◽  
Abdullah Faiq ◽  
Payam Noroozi Farhadi ◽  
...  

2020 ◽  
Vol 79 (10) ◽  
pp. 1130-1133
Author(s):  
Sahara J Cathcart ◽  
Ericka P Greene ◽  
Suzanne Z Powell ◽  
Anithachristy S Arumanayagam ◽  
Andreana L Rivera ◽  
...  

2019 ◽  
Vol 26 (3) ◽  
pp. 1749-1755 ◽  
Author(s):  
Csilla András ◽  
Levente Bodoki ◽  
Melinda Nagy-Vincze ◽  
Zoltán Griger ◽  
Emese Csiki ◽  
...  

Abstract Association between cancer and myositis has been extensively reported and malignancy is a potentially life-threating complication in myositis. In this retrospective study authors give an overview of Hungarian cancer-associated myositis (CAM) patients treated at a single centre managing 450 myositis patients. All patients were diagnosed according to Bohan and Peter. Statistical analysis of disease onset, age, sex, muscle, skin and extramuscular symptoms, muscle enzymes, presence of antibodies, treatment and prognosis was performed. 43 patients could be considered as having CAM. 83.72% had cancer within one year of diagnosis of myositis. Most common localizations were ductal carcinoma of breast and adenocarcinoma of lung. Significant differences were observed between CAM and the non-CAM control patients: DM:PM ratio was 2.31:1 vs. 0.87:1, respectively (p = 0.029), age at diagnosis was 56.60 ± 12.79 vs. 38.88 ± 10.88 years, respectively (p < 0.001). Tumour-treatment was the following: surgical removal in 55.81%, chemotherapy in 51.1%, radiotherapy in 39.53%, hormone treatment in 18.6%, combination therapy in 51.16% of patients. Muscle enzyme levels of patients undergoing surgery were significantly reduced after intervention. 36 patients died (83.72%); 25 DM (83.33%) and 11 PM patients (84.62%); 5 years survival was 15.4% for PM and 27.5% for DM. This study demonstrates that DM, distal muscle weakness, asymmetric Raynaud’s phenomenon, older age, ANA-negativity are risk factors for developing malignancy and polymyositis patients have less chance of long-lasting survival. It is very important to think about cancer and follow every single myositis patient in the clinical routine because survival rate of CAM is very poor.


2014 ◽  
Vol 66 ◽  
pp. S86-S87 ◽  
Author(s):  
Lisa G Rider ◽  
Abdullah Faiq ◽  
Payam Noroozi Farhadi ◽  
Nastaran Bayat ◽  
Lukasz Itert ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Ghada Al-Janobi ◽  
Hisham Alkhalidi ◽  
Mohammed A. Omair

Background. Heliotrope rash is one of the characteristic skin manifestations of juvenile dermatomyositis. It is a reddish-purple rash on the upper eyelids that is usually bilateral.Case Presentation. We report a boy who presented with unilateral heliotrope rash, Gottron’s papules, and muscle weakness. Muscle biopsy was consistent with inflammatory myositis. Patient was started on prednisolone and methotrexate with an excellent response in both the skin and muscles.Conclusion. Unilateral heliotrope rash can occur in patients with juvenile dermatomyositis. Being a paraneoplastic condition caution should be taken not to miss any underlying malignancy.


Sign in / Sign up

Export Citation Format

Share Document